This site is intended for healthcare professionals only
LoginRegister
After Blackstone, Baring PE, Torrent Pharma in race to acquire Hamied familys stake in Cipla: ReportAfter Blackstone, Baring PE, Torrent Pharma in race to acquire Hamied family's stake in Cipla:...
Natco Pharma gets 7 USFDA observations for Kothur Pharma DivisionConcord Biotech gets USFDA EIR for Limbasi facility
Roche unveils new PCR test to improve Vaginitis Diagnosis in countries following CE MarkRoche reports inadvertent disclosure in lung cancer immunotherapy study
Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye DeviceMedtronic elevates profit forecast as surgeries return to pre pandemic levels
Eli Lilly Omvoh secures USFDA approval as single-injection maintenance regimen in adults with ulcerative colitisRetevmo demonstrates superior progression free survival compared to approved Multikinase Inhibitors...
USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers SquibbBristol Myers Squibb gets European Commission nod for Opdivo as adjuvant treatment for patients with...
AstraZeneca to Invest USD 15 Billion in China by 2030CDSCO Panel rejects AstraZeneca's proposal to amend warning statement of Goserelin Acetate Depot...
Caplin Steriles Secures USFDA Approval for Generic Methylprednisolone InjectionMarksans Pharma Mucus loosening drug Guaifenesin ER bags USFDA okay
CDSCO Panel Flags Trial Death, Seeks Causality Report from Reliance Life Sciences on EtanerRelABB India bags order to automate Reliance Life Sciences biopharmaceutical facilities
Boehringer Ingelheim latest to sue US over drug price negotiation planBoehringer Ingelheim latest to sue US over drug price negotiation plan
Glenmarks Telma Surpasses Rs 1,000 Crore Revenue, Recognized in Harvard Case StudyGlenmark, Teva to pay Rs 2118 crore over drug price-fixing
USFDA places partial clinical hold on Magrolimab studies in acute myeloid leukemia: Gilead SciencesUSFDA places partial clinical hold on Magrolimab studies in acute myeloid leukemia: Gilead Sciences
X